Longevity Startups
430 companies tagged Longevity, with their investors and founders.
Evity combines AI with expert validation to surface trusted longevity-science insights, building infrastructure intended for use across research, education, and care delivery. It aims to make longevity practical and measurable for both individuals and the healthcare systems responsible for their care.
2 investors
EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD). The therapy blocks pathological FGF23–FGFR4 signaling in cardiomyocytes to prevent maladaptive cardiac hypertrophy and fibrosis.
2 investors
Fittr operates a health and fitness platform connecting users with coaches and doctors, and offers diagnostic testing that combines blood biomarkers, clinical history, and lifestyle data to build a "digital twin" for assessing health risks. The service targets individuals pursuing fitness and longevity goals.
2 investors
Gila Therapeutics is a clinical-stage biotech company developing a topical lingual signaling platform that delivers micro-dose PYY dissolving on the tongue to activate brain regions regulating food intake and metabolism. Its treatments target obesity, type 2 diabetes, and associated cardiometabolic disorders.
2 investors
GlycoX develops a food ingredient derived from a native plant oil that aims to reduce post-meal blood-sugar spikes and support metabolic health. It is positioned as a preventive, food-based approach to glucose control and longevity for everyday consumers.
2 investors
Groove provides a virtual bone health program for people with osteoporosis, pairing each member with a physician and a dedicated physical therapist for at-home strength training and monitoring. The service targets older adults in the U.S. and is covered by Original Medicare.
2 investors
iHeart Japan is a regenerative medicine company developing cell-therapy products for the heart using iPS (induced pluripotent stem) cells, aiming to provide new treatment options for heart disease.
2 investors
Imel Biotherapeutics is a biotech company focused on mitochondrial biology, targeting mitochondrial dysfunction implicated in aging, cellular senescence, and T cell exhaustion in the elderly population.
2 investors
InsideTracker provides personalized insights into blood work and biomarker analysis to help individuals optimize their health and longevity. The platform offers testing and recommendations for consumers and enterprises focused on health optimization.
2 investors
Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology. It operates an integrated drug discovery platform combining synthetic biology, chemical data, and machine learning.
2 investors
Kind Biotechnology develops the ION platform, which uses artificial genomic constructs to grow interconnected peripheral organs for xenotransplantation. The company aims to address organ scarcity in transplant medicine to treat age-related organ failure and extend healthy human lifespan.
2 investors
L-Nutra develops nutrition-based, plant-derived products and programs aimed at improving healthspan, preventing and treating disease, and extending life. The company combines nutrition science with AI technology, lifestyle education, and health professionals to promote proactive health care.
2 investors
libify provides home care solutions for people in need of care and their relatives, including home emergency call systems with fall detection and GPS, care supply boxes of hygiene products, and certified online care courses. Based in Munich, it handles applications with statutory and private care insurance funds and offers a 24-hour German emergency call center.
2 investors
Lindora offers medically supervised metabolic health and weight-management programs built around lab work, body composition, and hormone panels, with treatments such as hormone therapy (HRT/TRT), GLP-1 therapy, IV nutrient therapy, body contouring, and high-protein nutrition programs. A provider translates a member's lab data into a personalized plan that is reviewed and adjusted every 90 days across six metabolic pillars.
2 investors
Longeveron is a clinical-stage biotechnology company developing allogeneic cellular therapies for life-threatening conditions affecting children and the elderly. Its investigational candidate is being evaluated for indications including Hypoplastic Left Heart Syndrome, Pediatric Dilated Cardiomyopathy, Alzheimer's Disease, and age-related frailty.
2 investors
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.
2 investors
Powerhouse.bio is a biotechnology company that combines experimental biology with applied machine learning. The company works at the intersection of biology and computational science.
2 investors
Mederva Health provides healthcare data analysis and interpretation tools that help individuals understand their health information and take actionable steps toward longer, healthier lives, with a focus on accessibility for the general population.
2 investors
Moira Club is a membership-based concierge wellness platform for people aging at home, pairing a support team with personalized vitality and care plans covering longevity, strength, and daily health coordination. It handles tasks such as appointment reminders, prescription refills, meal coordination, and check-ins to help members live independently.
2 investors
Lighthouse Pharmaceuticals develops precision therapeutics for major unmet medical needs, with a lead program (LHP588), a gingipain inhibitor being tested in the Phase 2 SPRING trial for P. gingivalis-positive Alzheimer's disease. The company works in the biotechnology and drug development space, using patient responder analyses and dose modeling to advance its clinical candidates.
2 investors
Mostdays operates Death Clock, a longevity platform that estimates users' life expectancy based on clinical studies, bloodwork, and health habits, and provides personalized longevity plans curated by doctors. It offers lab testing through Quest and Labcorp locations and a system that updates recommendations as users' habits and bloodwork change.
2 investors
Nagi Bioscience provides automated in vivo testing using the C. elegans model to measure lifespan, healthspan, and biological age, offered as both an on-site platform (SydLab One) and contract research services. It serves biotech, nutraceutical, and pharmaceutical companies working on aging and longevity interventions.
2 investors
Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.
2 investors
Neuroglee provides memory and dementia care programs, including support for care partners, delivered through value-based arrangements. It partners with value-based provider groups, health insurance plans, and other risk-bearing organizations to deliver evidence-based dementia care.
2 investors